Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.
about
Untangling tau imagingDrug Development in Alzheimer's Disease: The Contribution of PET and SPECTAdvances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Future Directions in Imaging Neurodegeneration.PET/SPECT imaging agents for neurodegenerative diseases.Molecular imaging of Alzheimer disease pathologyImaging biomarkers associated with cognitive decline: a review.Characterization of a brain permeant fluorescent molecule and visualization of Aβ parenchymal plaques, using real-time multiphoton imaging in transgenic miceSynthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's diseaseClinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric SymptomsAppropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationFluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer's Disease.Practical utility of amyloid and FDG-PET in an academic dementia center.Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.Harnessing the immune system for treatment and detection of tau pathology.Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease.Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.Biomarkers in Sporadic and Familial Alzheimer's Disease.Amyloid imaging in clinical trials.Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic micePerformance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.Quantification of 18F-florbetapir PET: comparison of two analysis methods.Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.Amyloid PET imaging: applications beyond Alzheimer's disease.[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV.Amyloid imaging in depression: a predictor of Alzheimer's disease?Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B.Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.Imaging Alzheimer's disease pathophysiology with PET.Preclinical Comparison of the Amyloid-β Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis.Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases.
P2860
Q26739091-67DC7FA6-0296-433D-A547-161BB8C8B273Q26749755-DFD24C20-D75B-426E-9211-C8FAE2A5672EQ30945416-07D70634-5C48-40D5-A0B8-DDEACAA6D6ADQ30996799-5C51281E-64C9-4B69-88FF-FFF5320FA697Q31162702-5DA5A3D6-8778-4E74-A2A5-4E59961D6B76Q34156602-5DCCBC5D-A20E-4861-B89A-9B8FC6963451Q34651135-ADD820E1-E9E4-4484-BA36-6BEBC7ADAC1CQ35185786-197E26A2-34FF-496C-BD04-A722C5FA43ECQ35213005-33724F81-3F78-44A7-B00D-EB77A529CABFQ35772537-A8189654-451D-4CCC-A666-48CD6A1DF197Q35893095-A4AC1F34-0810-4BEE-9845-7C4C8ADEADCAQ37069527-AD36E7E0-1213-49D0-88F3-29CD6BBCAC99Q37386143-46149C59-8F47-4104-ACD5-3F570E583E5CQ37518041-824FA5AD-0644-44AC-9D32-2B8149AA2F39Q37693470-8219F35B-9D6C-42BC-9D39-6C947616A4D3Q37727300-7D460F1C-317B-4E21-AC50-85ED79605BE6Q38194049-AEDF5A73-6F94-4DCF-9709-8D9BA9A9438EQ38199617-A058EC0F-3453-4FE0-9FB1-22642AA4C7B6Q38219529-2B79C050-7385-4F3F-9217-205541CF5300Q38592041-37022042-81E9-4EF1-AED6-EEFC80060E27Q38647907-44FC9ECC-F30F-4B63-A226-AAACDE31B4DEQ38877410-732BE6C5-8045-482F-8653-76AC22AC1311Q38903262-4D1536D9-90B7-4E04-8AA9-9B5DA2DA5908Q39775642-B8E7E71B-B768-4969-9168-678D6338A4EDQ41189152-A470CE2B-FBCA-44E0-8C6E-B55B1589874BQ41477369-F0EE480D-5190-4F80-B220-E4EA5A1DE9AEQ41587883-03EF14ED-FD93-43C9-BB4D-917AE7B821AAQ43161462-BD9A1AF8-A765-4840-A633-BCBC7BB8D6A2Q43597594-6170EDEB-11DE-48C4-B77B-6911E152215EQ44901723-393F9D04-4AE7-44F3-92A9-B8AD6CB25FF3Q47547512-6473D7B8-544D-45AA-B652-F502D90A9234Q47624462-E8974585-D9E8-42AA-9DA5-4436AACF969AQ48339409-1AE356A5-5177-4625-8A09-F3CA3434827AQ48609636-F6153906-4BDC-4ED8-BA98-47CE45CB51CDQ48759194-06542514-B9F8-4B01-974C-FEB258047217Q49295547-93EB3674-B3D0-42DB-B02E-46C0C8BAC338Q50044294-E4E801E3-D5C3-41B4-9010-9A123F537A99Q53025487-449A74A5-96A8-45E5-A5AB-8B9414523F94Q55344088-274E5421-AF14-4EAA-8A6D-86D63D5E0A03
P2860
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Head-to-head comparison of 11C ...... imaging in aging and dementia.
@en
Head-to-head comparison of 11C-PiB and 18F-AZD4694
@nl
type
label
Head-to-head comparison of 11C ...... imaging in aging and dementia.
@en
Head-to-head comparison of 11C-PiB and 18F-AZD4694
@nl
prefLabel
Head-to-head comparison of 11C ...... imaging in aging and dementia.
@en
Head-to-head comparison of 11C-PiB and 18F-AZD4694
@nl
P2093
P1476
Head-to-head comparison of 11C ...... imaging in aging and dementia.
@en
P2093
Christopher C Rowe
J Gordon Chan
Rachel S Mulligan
Samuel Svensson
Svetlana Pejoska
Victor L Villemagne
Zsolt Cselényi
P304
P356
10.2967/JNUMED.112.114785
P407
P577
2013-04-10T00:00:00Z